Interleukin 1 receptor antagonist and E-selectin concentrations: A comparison in patients with severe acute pancreatitis and severe sepsis

Journal of Critical Care

Volumn 14, Issue 2, 1999, Pages 63-68

  Hynninen, Marja ^a   Valtonen, Matti ^b   Markkanen, Helene ^b   Vaara, Martti ^b   Kuusela, Pentti ^b   Jousela, Irma ^b   Piilonen, Anneli ^b   Takkunen, Olli ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MULTIPLE ORGAN FAILURE; PANCREATITIS; SEPSIS; STATISTICAL ANALYSIS;

EID: 0033031968     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-9441(99)90015-1     Document Type: Article

References (26)

1. Rindelknecht H: Fatal pancreatitis, a consequence of excessive leukocyte stimulation. Int J Pankreatol 3:105-112, 1988
2. Kuhns DB, Alvord WG, Gallin JI: Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 171:145-152, 1995
3. Exley AR, Leese T, Holliday MP, et al: Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Cut 33:1126-1128, 1992
4. Heath DI, Cruickshank A, Gudgeon M, et al: Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 34:41-45, 1993
5. Leser H-G, Gross V, Scheibenbogen C, et al: Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 101:782-785, 1991
6. Gross V, Andreesen R, Leser HG, et al: Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 22:200-203, 1992
7. Granowitz EV, Clark BD, Mancilla J, et al: Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 266:12127-14150, 1991
8. Pruitt JH, Welborn MB, Edwards PD, et al: Increased soluble interleukin-1 type-II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87:3282-3288, 1996
9. Granowitz EV, Santos AA, Poutsiaka DD, et al: Production of interleukin-1 receptor antagonist during experimental endotoxemia. Lancet 338:1423, 1991
10. Lawrence MB, Springer TA: Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 64:1-20, 1991
11. x. Science 250:1130-1132, 1990
12. Newman W, Beall LD, Carson CW, et al: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150:644-654, 1993
13. Balthazar EJ, Robinson DL, Megibow AJ, et al: Acute pancreatitis: Value of CT in establishing prognosis. Radiology 174:331-336, 1990
14. Bradley EL III: A clinically based classification system for acute pancreatitis. Arch Surg 128:586-589, 1993
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992
16. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 13:818-829, 1985
17. Vincent J-L, Moreno R, Takala J, et al: The SOFA (Sepsis related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710, 1996
18. Foulis AK, Murray WR, Galloway D, et al: Endotoxaemia and complement activation in acute pancreatitis in man. Gut 23:656-661, 1992
19. Kingnorth A: Role of cytokines and their inhibitors in acute pancreatitis. Gut 40:1-4, 1997 (editorial)
20. Hurley J: Concordance of endotoxemia with gram-negative bacteremia in patients with gram-negative sepsis: A meta-analysis. J Clin Microbiol 32:2120-2127, 1992
21. Cummings J, Sessler CN, Beall LD, et al: Soluble E-selectin levels in sepsis and critical illness: Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 156:431-437, 1997
22. Opal SM, Fisher CJ, Dhainaut J-FA, et al: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial. Crit Care Med 25:1115-1123, 1997
23. Norman J, Franz M, Messina J, et al: Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117:648-654, 1995
24. Norman JG, Franz MG, Fink GS, et al: Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 221:625-634, 1995
25. Boldt J, Mueller M, Kuhn D, et al: Circulating adhesion molecules in the critically ill: A comparison between trauma and sepsis patients. Intensive Care Med 22:122-128, 1996
26. Cowley HC, Heney D, Gearing AJH, et al: Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study. Crit Care Med 22:651-657, 1994